Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023		Dec. 31, 2022
Investment securities, fair value	$ 1,567		$ 1,729
Investment securities, amortized cost basis	1,752		1,897
Net finance receivables	21,067		19,986
Financing receivable, allowance for credit loss	2,449		2,311
Restricted cash and restricted cash equivalents	580	[1]	461
Long-term debt	19,851		18,281
Other liabilities	$ 581		$ 616
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Common stock, shares authorized (in shares)	2,000,000,000		2,000,000,000
Common stock, shares issued (in shares)	120,245,297		121,042,125
Common stock, shares outstanding (in shares)	120,245,297		121,042,125
Treasury stock at cost (in shares)	14,872,259		13,813,476
Consolidated VIEs
Net finance receivables	$ 13,229		$ 10,432
Financing receivable, allowance for credit loss	1,480		1,126
Restricted cash and restricted cash equivalents	564		442
Long-term debt	11,917		9,361
Other liabilities	$ 26		$ 20

[1] Restricted cash and restricted cash equivalents primarily represent funds required to be used for future debt payments relating to our secured transactions.